國立高雄大學圖資館 |

Deciphering drug targets for Alzheimer's disease

Record Type:	Electronic resources : Monograph/item
Title/Author:	Deciphering drug targets for Alzheimer's diseaseedited by Dileep Kumar ... [et al.].
other author:	Kumar, Dileep.
Published:	Singapore :Springer Nature Singapore :2023.
Description:	xv, 381 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Alzheimer's diseaseTreatment.
Online resource:	https://doi.org/10.1007/978-981-99-2657-2
ISBN:	9789819926572$q(electronic bk.)

Deciphering drug targets for Alzheimer's disease
Deciphering drug targets for Alzheimer's disease[electronic resource] /edited by Dileep Kumar ... [et al.]. - Singapore :Springer Nature Singapore :2023. - xv, 381 p. :ill., digital ;24 cm.

Chapter 1.Deciphering New Drug Targets in Alzheimer's Disease -- Chapter 2. Novel Therapeutic Targets for Treating Alzheimer's Disease -- Chapter 3. Modified Investigation Tools and Techniques Useful in Alzheimer's Disease Research -- Chapter 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase1A (DYRK1A) Inhibitors: The Quest for a Disease-Modifying Treatment for Alzheimer's Disease -- Chapter 5. β-secretase as a primary drug target of Alzheimer disease: Function, Structure, and Inhibition -- Chapter 6. Endocrine Receptors: The Potential Therapeutic Targets for Alzheimer's -- Chapter 7. Calcium Channels as a Potential Therapeutic Target for Alzheimer's Disease -- Chapter 8. Traversing Through the Trajectory of Pathogenic Astrocytes in Alzheimer's Disease -- Chapter 9. Targeting Mitochondrial Dynamics as a Restorative Approach in the Treatment of Alzheimer's Disease -- Chapter 10. Epigenetic Therapy for Alzheimer's Disease -- Chapter 11. Exploring the Diverse Roles of GSK-3ß Kinase in Alzheimer's Disease -- Chapter 12. Role of Target Fishing in Discovery of Novel Anti-Alzheimer's Agents: In Silico Applications -- Chapter 13. Multi-Target Directed Ligand Approach in Anti-Alzheimer's Drug Discovery -- Chapter 14. Investigating the Role of Tau Proteins in Alzheimer's Disease-From Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain -- Chapter 15. The Overview of Drugs Used in Alzheimer's Disease and Their Molecular Targets.

This book explains the fundamental characteristics and biofunctionality of Alzheimer's Disease drug targets and provides up-to-date information on the full range of their biomedical applications. An introductory section gives an overview of the recent developments related to drug targets identified and studied related to Alzheimer's Disease and key developments from preclinical and clinical studies focusing on various molecular targets related to AD and dementia by subject experts all around the globe. Here, individual chapters address the progress and perspectives in human and non-human research, role of various biomarkers as an overview, advanced gene therapy, and novel compounds for therapeutic targets for Alzheimer's disease. The book will be essential reading for graduate students, scientists, and engineers in any of the biomedical research fields in which efforts are being made to utilize novel drug targets and develop effective strategies for new drug targeting and delivery in Alzheimer's disease treatment.

ISBN: 9789819926572$q(electronic bk.)

Standard No.: 10.1007/978-981-99-2657-2doiSubjects--Topical Terms:

188756
Alzheimer's disease
--Treatment.

LC Class. No.: RC523 / .D43 2023

Dewey Class. No.: 616.8311061

Deciphering drug targets for Alzheimer's disease
LDR:03505nmm a2200325 a 4500 001 647350
003 DE-He213
005 20230831135357.0
006 m d
007 cr nn 008maaau
008 240116s2023 si s 0 eng d
020 $a 9789819926572$q(electronic bk.)
020 $a 9789819926565$q(paper)
024 7 $a 10.1007/978-981-99-2657-2 $2 doi
035 $a 978-981-99-2657-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523 $b .D43 2023
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 616.8311061 $2 23
090 $a RC523 $b .D294 2023
245 0 0 $a Deciphering drug targets for Alzheimer's disease $h [electronic resource] / $c edited by Dileep Kumar ... [et al.].
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xv, 381 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1.Deciphering New Drug Targets in Alzheimer's Disease -- Chapter 2. Novel Therapeutic Targets for Treating Alzheimer's Disease -- Chapter 3. Modified Investigation Tools and Techniques Useful in Alzheimer's Disease Research -- Chapter 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase1A (DYRK1A) Inhibitors: The Quest for a Disease-Modifying Treatment for Alzheimer's Disease -- Chapter 5. β-secretase as a primary drug target of Alzheimer disease: Function, Structure, and Inhibition -- Chapter 6. Endocrine Receptors: The Potential Therapeutic Targets for Alzheimer's -- Chapter 7. Calcium Channels as a Potential Therapeutic Target for Alzheimer's Disease -- Chapter 8. Traversing Through the Trajectory of Pathogenic Astrocytes in Alzheimer's Disease -- Chapter 9. Targeting Mitochondrial Dynamics as a Restorative Approach in the Treatment of Alzheimer's Disease -- Chapter 10. Epigenetic Therapy for Alzheimer's Disease -- Chapter 11. Exploring the Diverse Roles of GSK-3ß Kinase in Alzheimer's Disease -- Chapter 12. Role of Target Fishing in Discovery of Novel Anti-Alzheimer's Agents: In Silico Applications -- Chapter 13. Multi-Target Directed Ligand Approach in Anti-Alzheimer's Drug Discovery -- Chapter 14. Investigating the Role of Tau Proteins in Alzheimer's Disease-From Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain -- Chapter 15. The Overview of Drugs Used in Alzheimer's Disease and Their Molecular Targets.
520 $a This book explains the fundamental characteristics and biofunctionality of Alzheimer's Disease drug targets and provides up-to-date information on the full range of their biomedical applications. An introductory section gives an overview of the recent developments related to drug targets identified and studied related to Alzheimer's Disease and key developments from preclinical and clinical studies focusing on various molecular targets related to AD and dementia by subject experts all around the globe. Here, individual chapters address the progress and perspectives in human and non-human research, role of various biomarkers as an overview, advanced gene therapy, and novel compounds for therapeutic targets for Alzheimer's disease. The book will be essential reading for graduate students, scientists, and engineers in any of the biomedical research fields in which efforts are being made to utilize novel drug targets and develop effective strategies for new drug targeting and delivery in Alzheimer's disease treatment.
650 0 $a Alzheimer's disease $x Treatment. $3 188756
650 0 $a Drug targeting. $3 194481
650 1 4 $a Biomedical Research. $3 243625
650 2 4 $a Biological Sciences. $3 503847
650 2 4 $a Neuroscience. $3 297547
650 2 4 $a Biotechnology. $3 188829
650 2 4 $a Drug Delivery. $3 911847
700 1 $a Kumar, Dileep. $3 956716
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-2657-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)